Efficacy and safety of nivolumab (Nivo) plus ipilimumab (Ipi) in patients (pts) with recurrent/metastatic (R/M) cervical cancer: Results from CheckMate 358

R. W. Naumann; A. Oaknin; T. Meyer; J. M. Lopez-Picazo; C. Lao; Y-J. Bang; V. Boni; W. H. Sharfman; J. C. Park; L. A. Devriese; K. Harano; C. H. Chung; S. L. Topalian; K. Zaki; T. Chen; J. Gu; B. Li; A. Barrows; A. Horvath; K. N. Moore

Efficacy and safety of nivolumab (Nivo) plus ipilimumab (Ipi) in patients (pts) with recurrent/metastatic (R/M) cervical cancer: Results from CheckMate 358

R. W. Naumann, A. Oaknin, T. Meyer, J. M. Lopez-Picazo, C. Lao, Y-J. Bang, V. Boni, W. H. Sharfman, J. C. Park, L. A. Devriese, K. Harano, C. H. Chung, S. L. Topalian, K. Zaki, T. Chen, J. Gu, B. Li, A. Barrows, A. Horvath, K. N. Moore

Dept of Medical Oncology

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Pages (from-to)	898-+
Journal	Annals of Oncology
Volume	30
Publication status	Published - Oct 2019

Cite this

Naumann, R. W., Oaknin, A., Meyer, T., Lopez-Picazo, J. M., Lao, C., Bang, Y.-J., Boni, V., Sharfman, W. H., Park, J. C., Devriese, L. A., Harano, K., Chung, C. H., Topalian, S. L., Zaki, K., Chen, T., Gu, J., Li, B., Barrows, A., Horvath, A., & Moore, K. N. (2019). Efficacy and safety of nivolumab (Nivo) plus ipilimumab (Ipi) in patients (pts) with recurrent/metastatic (R/M) cervical cancer: Results from CheckMate 358. Annals of Oncology, 30, 898-+.

@article{c9b089d06485449ebbbc53b36ad374e5,

title = "Efficacy and safety of nivolumab (Nivo) plus ipilimumab (Ipi) in patients (pts) with recurrent/metastatic (R/M) cervical cancer: Results from CheckMate 358",

author = "Naumann, {R. W.} and A. Oaknin and T. Meyer and Lopez-Picazo, {J. M.} and C. Lao and Y-J. Bang and V. Boni and Sharfman, {W. H.} and Park, {J. C.} and Devriese, {L. A.} and K. Harano and Chung, {C. H.} and Topalian, {S. L.} and K. Zaki and T. Chen and J. Gu and B. Li and A. Barrows and A. Horvath and Moore, {K. N.}",

year = "2019",

month = oct,

language = "English",

volume = "30",

pages = "898--+",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

}

Naumann, RW, Oaknin, A, Meyer, T, Lopez-Picazo, JM, Lao, C, Bang, Y-J, Boni, V, Sharfman, WH, Park, JC, Devriese, LA, Harano, K, Chung, CH, Topalian, SL, Zaki, K, Chen, T, Gu, J, Li, B, Barrows, A, Horvath, A & Moore, KN 2019, 'Efficacy and safety of nivolumab (Nivo) plus ipilimumab (Ipi) in patients (pts) with recurrent/metastatic (R/M) cervical cancer: Results from CheckMate 358', Annals of Oncology, vol. 30, pp. 898-+.

TY - JOUR

T1 - Efficacy and safety of nivolumab (Nivo) plus ipilimumab (Ipi) in patients (pts) with recurrent/metastatic (R/M) cervical cancer: Results from CheckMate 358

AU - Naumann, R. W.

AU - Oaknin, A.

AU - Meyer, T.

AU - Lopez-Picazo, J. M.

AU - Lao, C.

AU - Bang, Y-J.

AU - Boni, V.

AU - Sharfman, W. H.

AU - Park, J. C.

AU - Devriese, L. A.

AU - Harano, K.

AU - Chung, C. H.

AU - Topalian, S. L.

AU - Zaki, K.

AU - Chen, T.

AU - Gu, J.

AU - Li, B.

AU - Barrows, A.

AU - Horvath, A.

AU - Moore, K. N.

PY - 2019/10

Y1 - 2019/10

M3 - Meeting Abstract

SN - 0923-7534

VL - 30

SP - 898-+

JO - Annals of Oncology

JF - Annals of Oncology

ER -